相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function Insights From EMPEROR-Reduced
Faiez Zannad et al.
CIRCULATION (2021)
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Results of DAPA-HF
Pardeep S. Jhund et al.
CIRCULATION (2021)
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction A Report of the American College of Cardiology Solution Set Oversight Committee
Thomas M. Maddox et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
John R. Teerlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial
Jesper Jensen et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Kidney Function and Outcomes in Patients Hospitalized With Heart Failure
Ravi B. Patel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients with Heart Failure with Reduced Ejection Fraction
Wendy McCallum et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Erik J. M. van Bommel et al.
KIDNEY INTERNATIONAL (2020)
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
Eileen O'Meara et al.
CANADIAN JOURNAL OF CARDIOLOGY (2020)
Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology
Wilfried Mullens et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Paul W. Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study
Udo Bavendiek et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
Stephen J. Greene et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease
Aaron M. Hein et al.
JACC-HEART FAILURE (2019)
Acute declines in estimated glomerular filtration rate on enalapril and mortality and cardiovascular outcomes in patients with heart failure with reduced ejection fraction
Wendy McCallum et al.
KIDNEY INTERNATIONAL (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology
Wilfried Mullens et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial
David M. Charytan et al.
KIDNEY INTERNATIONAL (2019)
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure
Eric J. Velazquez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
Dipak Kotecha et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Medical Therapy for Heart Failure With Reduced Ejection Fraction
Stephen J. Greene et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
Kevin Damman et al.
JACC-HEART FAILURE (2018)
Exploiting the Natriuretic Peptide Pathway to Preserve Glomerular Filtration in Heart Failure
Wilfried Mullens et al.
JACC-HEART FAILURE (2018)
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study
W. Ouwerkerk et al.
EUROPEAN HEART JOURNAL (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis
Kevin Quach et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme
Kevin Damman et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure The ATOMIC-AHF Study
John R. Teerlink et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The kidney in heart failure: an update
Kevin Damman et al.
EUROPEAN HEART JOURNAL (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Early and Late Effects of High- Versus Low-Dose Angiotensin Receptor Blockade on Renal Function and Outcomes in Patients With Chronic Heart Failure
Michael S. Kiernan et al.
JACC-HEART FAILURE (2015)
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
Kevin Damman et al.
EUROPEAN HEART JOURNAL (2014)
Terminology and definition of changes renal function in heart failure
Kevin Damman et al.
EUROPEAN HEART JOURNAL (2014)
The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'
Frederik H. Verbrugge et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey
Vincent M. van Deursen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction
Hannah Clark et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Co-morbidities in heart failure
Vincent M. van Deursen et al.
HEART FAILURE REVIEWS (2014)
Current Evidence on Treatment of Patients With Chronic Systolic Heart Failure and Renal Insufficiency
Kevin Damman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Worsening Renal Function and Outcome in Heart Failure Patients With Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment
Kevin Damman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Interaction between baseline and early worsening of renal function and efficacy of reninangiotensinaldosterone system blockade in patients with heart failure: insights from the Val-HeFT study
Anastasia Lesogor et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: Insights from the SOLVD Treatment trial
C. Barrett Bowling et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Potential Effects of Digoxin on Long-Term Renal and Clinical Outcomes in Chronic Heart Failure
Jeffrey M. Testani et al.
JOURNAL OF CARDIAC FAILURE (2013)
Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function Analyses of the EMPHASIS-HF Study Subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)
Romain Eschalier et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Influence of Baseline and Worsening Renal Function on Efficacy of Spironolactone in Patients With Severe Heart Failure
Orly Vardeny et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Cardiorenal Syndrome in Heart Failure
Kevin Damman et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2011)
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial
Davide Castagno et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg et al.
LANCET (2010)
Differential associations between renal function and modifiable risk factors in patients with chronic heart failure
Tom D. J. Smilde et al.
CLINICAL RESEARCH IN CARDIOLOGY (2009)
Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial
Alain Cohen-Solal et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
The Influence of Renal Function on Clinical Outcome and Response to β-Blockade in Systolic Heart Failure: Insights From Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)
Jalal K. Ghali et al.
JOURNAL OF CARDIAC FAILURE (2009)
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
Marvin A. Konstam et al.
LANCET (2009)
Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction
Powell Jose et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
The severe cardiorenal syndrome: 'Guyton revisited'
LG Bongartz et al.
EUROPEAN HEART JOURNAL (2005)
Renal function, digoxin therapy, and heart failure outcomes: Evidence from the Digoxin Intervention Group Trial
MG Shlipak et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial
CB Granger et al.
LANCET (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
JJV McMurray et al.
LANCET (2003)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme
MA Pfeffer et al.
LANCET (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
JN Cohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
HJ Dargie et al.
LANCET (2001)
分享论文
